Fifth Third Bancorp
BIB icon

Fifth Third Bancorp’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Fifth Third Bancorp’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-800
Closed -$79K – 2642
2021
Q2 		$79K Buy
+800
New +$69.8K ﹤0.01% 1274

Other funds holding BIB

Howard Capital Management
Howard Capital Management Roswell, Georgia $8.26B AUM 36.73% 1-Year Est. Return
Geneos Wealth Management
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Old Mission Capital
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
Capital Investment Advisors
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
Orion Portfolio Solutions
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UMC
United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return

Fifth Third Bancorp's BIB Position: Q3 2021 in Review

Fifth Third Bancorp sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2021, closing a stake of 800 shares — an estimated $79K sold.

Fifth Third Bancorp first reported a position in BIB in Q2 2021 and held it in 1 quarter. The position peaked at $79K in Q2 2021. 32 funds tracked by Wall St. Rank hold BIB as of Q3 2021.

  • Fifth Third Bancorp reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 800 ProShares Ultra NASDAQ Biotechnology shares in Q3 2021, an estimated $79K.
  • Fifth Third Bancorp first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2021 and held it in 1 quarter.
  • Fifth Third Bancorp's ProShares Ultra NASDAQ Biotechnology position peaked at $79K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2021.

Based on Fifth Third Bancorp's 13F filing for Q3 2021, filed 15 Oct 2021.